HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.

Abstract
The in vitro sensitivity of human melanoma cell lines to conjugates of whole abrin or ricin linked through disulfide bonds to the monoclonal antimelanoma antibody 9.2.27 was studied. After passage of the conjugates through a Sepharose 4B column to remove molecular species with exposed binding sites on their B-chains, toxicity of the conjugates to different melanoma cell lines and nonmelanoma tumor lines was assessed by measuring their ability to inhibit cellular protein synthesis. The abrin conjugate was far more toxic to the target cells than the corresponding ricin conjugate. The 8 melanoma cell lines studied differed widely in their sensitivities to the abrin conjugate. The differences were associated with concomitant large differences in the sensitivities of the cells to the native toxins, and the significance of the level of the antigen expression became apparent only when the sensitivities of the different cell lines were normalized with respect to their sensitivity to native abrin. The observed relationship could not be accounted for by unspecific binding via the B-chain binding site of the immunotoxin. The differential sensitivity of the melanoma cell lines to the immunotoxin seems to be related to inherent differences between the cells in their ability to internalize and to process immunotoxins and toxins. The findings may have considerable practical implications.
AuthorsA Godal, O Fodstad, A C Morgan, A Pihl
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 77 Issue 6 Pg. 1247-53 (Dec 1986) ISSN: 0027-8874 [Print] United States
PMID3491924 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Immunotoxins
  • Melanoma-Specific Antigens
  • Neoplasm Proteins
  • Plant Proteins
  • Abrin
  • Ricin
Topics
  • Abrin (pharmacology)
  • Antibodies, Monoclonal (therapeutic use)
  • Antigens, Neoplasm
  • Binding Sites
  • Cell Line
  • Fibroblasts (drug effects)
  • Humans
  • Immunotoxins (pharmacology)
  • Melanoma (immunology, pathology)
  • Melanoma-Specific Antigens
  • Neoplasm Proteins (analysis)
  • Plant Proteins (pharmacology)
  • Ricin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: